Robert K. Keast

TL;DR: This study compares the long‐term efficacy and cost implications of CBA and CF‐RFA in patients with PAF to determine whether contact force sensing and CBA with the second‐generation catheter have similar procedural costs and long-term outcomes.

TL;DR: In a joint effort with physicians, administration, and suppliers, and in the spirit of partnership, the University of Michigan Health System has developed and implemented a model that illustrates the opportunities to be gained.

TL;DR: The purpose of this study was to compare procedural efficacy, safety, clinical outcomes, and cost of CA for AF performed with MAC versus GA.

TL;DR: Early results suggest that competitive bidding with market-share guarantee to a preferred vendor or two initially resulted in moderate cost savings, but in 2003 this institution embarked on a novel approach in which the price to be paid was defined, and the vendors were challenged to meet that price.

TL;DR: In an attempt to further reduce operating costs, in 2004 this institution embarked on a novel approach in which it defined the price to be paid for interventional cardiology supplies and challenged vendors to meet that price.